Bank Of America Corp Assembly Biosciences, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.65 - $1.25 $18 - $36	29 New	29 $0
Q4 2022 Feb 10, 2023	SELL	$1.09 - $20.4 $33,081 - $619,140	-30,350 Reduced 99.81%	59 $0
Q3 2022 Nov 14, 2022	SELL	$1.7 - $20.52 $647 - $7,818	-381 Reduced 1.24%	30,409 $50,000
Q2 2022 Aug 12, 2022	SELL	$1.35 - $2.29 $1,040 - $1,765	-771 Reduced 2.44%	30,790 $64,000
Q1 2022 May 16, 2022	BUY	$1.46 - $2.45 $34,534 - $57,952	23,654 Added 299.15%	31,561 $65,000
Q4 2021 Feb 08, 2022	SELL	$2.13 - $3.46 $57,565 - $93,509	-27,026 Reduced 77.37%	7,907 $18,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $62,708 - $77,886	-19,971 Reduced 36.37%	34,933 $121,000
Q2 2021 Sep 13, 2021	BUY	$3.8 - $4.56 $208,635 - $250,362	54,904 New	54,904 $213,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.